Morgan Stanley Downgrades Atea Pharmaceuticals (AVIR) to Underweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/4/2026

1. NKE
2. USO
3. SPY
4. ACN
5. NVDA
6. FICO
7. TRU
8. TLT
9. LAES
10. WBD

January 6, 2022 6:50 AM EST
Get Alerts AVIR Hot Sheet
Price: $5.13 +0.59%

Rating Summary:
    2 Buy, 2 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE

Morgan Stanley analyst Matthew Harrison downgraded Atea Pharmaceuticals (NASDAQ: AVIR) from Equalweight to Underweight with a price target of $7.00.


For an analyst ratings summary and ratings history on Atea Pharmaceuticals click here. For more ratings news on Atea Pharmaceuticals click here.


Shares of Atea Pharmaceuticals closed at $8.30 yesterday.


You May Also Be Interested In





Related Categories

Downgrades